Titan Pharmaceuticals (TTNP) Competitors

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

$7.32

+0.22 (+3.10%)

(As of 04/19/2024 ET)

TTNP vs. CHRO, CELZ, FRTX, PALI, FNCH, TCON, NSTGQ, KRBP, BCDA, and ALBT

Should you be buying Titan Pharmaceuticals stock or one of its competitors? The main competitors of Titan Pharmaceuticals include Chromocell Therapeutics (CHRO), Creative Medical Technology (CELZ), Fresh Tracks Therapeutics (FRTX), Palisade Bio (PALI), Finch Therapeutics Group (FNCH), TRACON Pharmaceuticals (TCON), NanoString Technologies (NSTGQ), Kiromic BioPharma (KRBP), BioCardia (BCDA), and Avalon GloboCare (ALBT). These companies are all part of the "biological products, except diagnostic" industry.

Titan Pharmaceuticals vs.

Titan Pharmaceuticals (NASDAQ:TTNP) and Chromocell Therapeutics (NYSE:CHRO) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, community ranking, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

: Chromocell Therapeutics has a net margin of 0.00% compared to Titan Pharmaceuticals' net margin of -2,014.71%. Chromocell Therapeutics' return on equity of 0.00% beat Titan Pharmaceuticals' return on equity.
Company Net Margins Return on Equity Return on Assets
Titan Pharmaceuticals -2,014.71% -165.90% -105.75%
Chromocell Therapeutics N/A N/A N/A
: In the previous week, Titan Pharmaceuticals had 2 more articles in the media than Chromocell Therapeutics. MarketBeat recorded 2 mentions for Titan Pharmaceuticals and 0 mentions for Chromocell Therapeutics. Chromocell Therapeutics' average media sentiment score of 0.00 beat Titan Pharmaceuticals' score of -0.36 indicating that Chromocell Therapeutics is being referred to more favorably in the news media.
Company Overall Sentiment
Titan Pharmaceuticals Neutral
Chromocell Therapeutics Neutral
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Titan Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
Chromocell Therapeutics
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: Titan Pharmaceuticals received 335 more outperform votes than Chromocell Therapeutics when rated by MarketBeat users.
Company Underperform Outperform
Titan Pharmaceuticals Outperform Votes
335
57.36%
Underperform Votes
249
42.64%
Chromocell Therapeutics N/A N/A
: Chromocell Therapeutics has lower revenue, but higher earnings than Titan Pharmaceuticals.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Titan Pharmaceuticals $1K 6,690.02 -$5.57M -$8.20 -0.89
Chromocell Therapeutics N/A N/A N/A N/A N/A
: 31.5% of Titan Pharmaceuticals shares are owned by institutional investors. Comparatively, 78.0% of Chromocell Therapeutics shares are owned by institutional investors. 24.9% of Titan Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Company	Net Margins	Return on Equity	Return on Assets
Titan Pharmaceuticals	-2,014.71%	-165.90%	-105.75%
Chromocell Therapeutics	N/A	N/A	N/A

Company	Overall Sentiment
Titan Pharmaceuticals	Neutral
Chromocell Therapeutics	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Chromocell Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Underperform	Outperform
Titan Pharmaceuticals	Outperform Votes 335 57.36%	Underperform Votes 249 42.64%
Chromocell Therapeutics	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Pharmaceuticals	$1K	6,690.02	-$5.57M	-$8.20	-0.89
Chromocell Therapeutics	N/A	N/A	N/A	N/A	N/A

Summary

Chromocell Therapeutics beats Titan Pharmaceuticals on 5 of the 9 factors compared between the two stocks.

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

Get Titan Pharmaceuticals News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TTNP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TTNP vs. The Competition

Export to Excel

Metric	Titan Pharmaceuticals	Biological Products Industry	Medical Sector	NASDAQ Exchange
Market Cap	$6.69M	$2.47B	$4.80B	$7.30B
Dividend Yield	N/A	2.83%	2.94%	4.01%
P/E Ratio	-0.89	43.09	269.16	20.04
Price / Sales	6,690.02	360.64	2,454.86	89.18
Price / Cash	N/A	156.48	47.18	34.82
Price / Book	0.83	3.65	4.55	4.16
Net Income	-$5.57M	-$49.12M	$104.05M	$214.20M
7 Day Performance	0.82%	-8.72%	-4.46%	-3.53%
1 Month Performance	-0.28%	-10.55%	-6.03%	-4.16%
1 Year Performance	-53.97%	2.26%	6.72%	3.26%

Titan Pharmaceuticals Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CHRO Chromocell Therapeutics	0 of 5 stars	$1.82 -6.7%	N/A	N/A	$7.06M	N/A	0.00	3
CELZ Creative Medical Technology	0 of 5 stars	$5.20 -0.2%	N/A	-23.8%	$7.07M	$10,000.00	-1.40	4	News Coverage Positive News
FRTX Fresh Tracks Therapeutics	0 of 5 stars	$0.90 +2.3%	N/A	+44.5%	$5.37M	$8.01M	-0.64	4	Gap Up
PALI Palisade Bio	3.0941 of 5 stars	$5.93 +42.5%	$131.25 +2,113.3%	-82.1%	$5.04M	$250,000.00	-0.22	12	Analyst Report Gap Up High Trading Volume
FNCH Finch Therapeutics Group	0.5346 of 5 stars	$3.10 +38.4%	N/A	-80.2%	$4.99M	$110,000.00	-0.07	18	Gap Down High Trading Volume
TCON TRACON Pharmaceuticals	0.9095 of 5 stars	$1.71 -5.0%	$60.00 +3,408.8%	-94.2%	$3.90M	$12.05M	-0.33	17	Analyst Report Stock Split
NSTGQ NanoString Technologies	0 of 5 stars	$0.08 flat	N/A	N/A	$3.76M	$127.26M	-0.02	550	News Coverage Positive News Gap Down
KRBP Kiromic BioPharma	0 of 5 stars	$2.91 +3.6%	N/A	-34.9%	$3.75M	N/A	-0.19	35	Gap Up
BCDA BioCardia	1.7044 of 5 stars	$0.36 -2.7%	$4.00 +998.0%	-81.2%	$9.74M	$480,000.00	-0.66	16	Positive News
ALBT Avalon GloboCare	0 of 5 stars	$0.31 +3.3%	N/A	-84.2%	$3.45M	$1.20M	0.00	5	Positive News Gap Up

Related Companies and Tools

Related Companies:

Top 10 Stock Comparisons

This page (NASDAQ:TTNP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Titan Pharmaceuticals (TTNP) Competitors

TTNP vs. CHRO, CELZ, FRTX, PALI, FNCH, TCON, NSTGQ, KRBP, BCDA, and ALBT

Titan Pharmaceuticals vs.

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TTNP vs. The Competition

Titan Pharmaceuticals Competitors List

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info